PRAK-03202
/ Akers Biosci, Premas Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 29, 2023
VLP-ELISA for the Detection of IgG Antibodies against Spike, Envelope, and Membrane Antigens of SARS-CoV-2 in Indian Population.
(PubMed, Vaccines (Basel))
- "In conclusion, we have successfully developed an in-house VLP-ELISA to detect IgG antibodies against three antigens of SARS-CoV-2 as a simple and affordable alternative test."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
October 12, 2021
PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2.
(PubMed, Heliyon)
- "Peripheral blood mononuclear cells from convalescent patients showed lymphocyte proliferation and elevated interferon levels suggestive of epitope conservation and induction of T helper 1-biased cellular immune response when exposed to PRAK-03202. These data support further clinical development and testing of PRAK-03202 for use in humans."
Journal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1